Parachute
Parachute operates a tech-enabled plasma donation platform across 51 centers in 17 U.S. states, paying individual donors through a mobile app with tiered compensation, and supplying collected plasma to fractionators for therapeutic processing.
- Company typePrivate
- Founded2021
- HeadquartersAustin, United States
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Parachute does
Parachute (Join Parachute, LLC) is an Austin, Texas-based plasma donation company founded around 2021 that operates a technology-enabled platform for collecting source plasma. The company runs 51 physical donation centers across 17 U.S. states (with the heaviest presence in Texas at 11 centers, followed by North Carolina with 8 and Georgia with 6), generating revenue by paying donors for their plasma and selling the collected supply to fractionation facilities where it is processed into life-saving therapeutics. Its customers are individual donors—primarily adults aged 18–64 seeking supplemental income, including students, working adults, and retirees—acquired and retained primarily through a self-serve mobile app on iOS and Android.
The company's product stack centers on three components: a proprietary mobile app (developed by Buoy Software) that handles donor onboarding, scheduling, real-time availability, payments, referrals, and a 7-tier loyalty program in which donors earn higher per-donation rates based on donation frequency within a 30-day cycle; physical plasmapheresis centers where collection occurs via apheresis machines that return red blood cells and other components to the donor; and the Join Parachute Visa Prepaid Card, issued through Pathward, N.A., which delivers same-day payment via direct deposit. Donor pricing is transparent and disclosed on the website: $30–$40 per donation based on loyalty tier, with new-donor bonuses up to $200 across the first three visits, time-incentive bonuses of $1–$15, and referral payouts up to $70 per referred friend who reaches a new level; maximum annual donor earnings cap around $4,000 for those who donate twice weekly.
The business model is asset-heavy and consumer-direct: Parachute pays donors per donation (its primary cost of goods) and monetizes through the plasma supply chain to fractionators, positioning itself as a modern alternative to legacy plasma operators through mobile-first scheduling, no-wait-time service, and a hospitality-driven facility design. Capital-intensive infrastructure expansion is funded through venture backing totaling approximately $148.75M across multiple rounds, including a $36.28M exempt offering filed in June 2023 and a $38.15M raise in April 2026 that the company was reported as leading Texas venture deals for that week. The go-to-market relies on a product-led growth motion in which the app itself is the primary acquisition and retention surface, supported by content marketing, organic social presence, and an aggressive donor-referral mechanism.
Parachute firmographics
Firmographics- Name
- Parachute
- Legal name
- Join Parachute, LLC
- Website
- https://joinparachute.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Parachute operates a tech-enabled plasma donation platform across 51 centers in 17 U.S. states, paying individual donors through a mobile app with tiered compensation, and supplying collected plasma to fractionators for therapeutic processing.
- Ownership category
- akta.pro rank
Parachute industry classification
Industry- Product category
- Plasma Donation Services
- akta.pro primary industry
- Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)
Keywords
Where Parachute is headquartered
LocationHeadquarters
- HQ city
- Austin
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Parachute business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Plasma Collection and Sale: Parachute collects plasma from donors and sells it to fractionation facilities where plasma proteins are extracted and turned into life-saving medicine. The company generates revenue from the plasma supply chain, paying donors per donation as a cost of goods.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Per donation | New Donor Bonus - Up to $200 for first 3 donations |
| Unit Pricing | Per donation | Base Payment - $30 to $40 per donation based on loyalty level |
| Usage-based | Per donation | Time Incentive Bonuses - $1 to $15 per appointment |
| Transaction based/ take rate | Per referral event | Referral Program - Up to $70 per referral |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Parachute product offering
Product offeringCore offering
Parachute (Join Parachute, LLC) operates a network of plasma donation centers across the United States where individuals can donate plasma for compensation. The company uses plasmapheresis to collect plasma, which is then sold to fractionation facilities for the production of life-saving medicines. Donors are supported through a proprietary mobile application that enables appointment booking, real-time earnings tracking, and same-day compensation.
Product overview
Parachute operates as a plasma donation marketplace connecting donors with plasma collection centers through its proprietary mobile app. The core offering consists of the Parachute App (for scheduling, earnings management, and loyalty tracking) paired with a network of physical plasma donation centers across the U.S. Donors earn compensation per donation with payment delivered via the Join Parachute Visa Prepaid Card issued by Pathward. The platform uses a tiered loyalty system (7 levels) and offers bonus incentives through challenges and referrals.
Differentiator
Problem solved
Functional benefit
Products and services
- Parachute Mobile App
- Parachute Plasma Donation Centers
Quantifiable outcome
- Up to $4,000 annual earnings for frequent donors
- +3 more outcomes
Companies that use Parachute
Customer profileSegments3 records
Ideal customer profiles1 record
Parachute technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Parachute partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Parachute competitors and assessment
Company assessmentBroad incumbents
- CSL Plasma: CSL Plasma is the world's largest plasma collection network, operating 350+ centers across the U.S. and globally as a subsidiary of CSL Behring (a major fractionator). It is the dominant direct competitor to Parachute, with much greater scale, vertically integrated offtake, and brand recognition.
- Grifols Plasma: Grifols operates 300+ plasma collection centers globally and is one of the largest integrated plasma fractionators. Directly comparable to Parachute in core donation activity, with the additional advantage of being a downstream fractionator buyer of its own and third-party plasma.
Direct peers
- BioLife Plasma Services: BioLife operates 200+ U.S. plasma donation centers as a subsidiary of Takeda, supplying plasma for fractionation into therapeutics. It is the closest direct competitor to Parachute in target donor demographics, payment structure, and center-based collection model.
- Octapharma Plasma: Octapharma Plasma operates 180+ donation centers in the U.S. and is part of Octapharma, a global fractionator. Direct head-to-head competitor to Parachute in donor acquisition, per-donation pricing, and center footprint expansion.
- Kedrion (U.S. operations): Kedrion operates U.S. plasma collection centers feeding its fractionation business. Direct competitor in plasma collection with similar center-based, donor-compensated model, though smaller U.S. footprint than CSL/BioLife/Grifols.
- BPL Plasma: BPL Plasma operates a growing U.S. donation center network tied to Bio Products Laboratory's fractionation business. Comparable as a smaller, scaling independent plasma collector competing in similar U.S. geographies.
- Immunotek BioCenters: Immunotek operates a multi-state U.S. plasma donation center network. Comparable as a privately held, non-fractionator plasma collector competing for similar donor demographics in overlapping geographies.
Emerging players
- ADMA BioCenters: ADMA BioCenters is a division of ADMA Biologics operating a smaller but growing U.S. plasma center network focused on specialty/special-immune plasma. Comparable to Parachute as an independent collector, though more vertically integrated into finished therapies.
Regional players
- Plasma Biological Services / PlasmaSource: PlasmaSource operates regional plasma donation centers in select U.S. states. Comparable as a smaller regional collector; relevant for understanding geographic overlap and competition for donors in Parachute's footprint.
Others
- Haemonetics: Haemonetics is a leading manufacturer of plasmapheresis collection devices and software (e.g., PCS2, NexSys PCS) used by plasma centers including Parachute. Not a direct competitor but a critical supplier/infrastructure provider whose technology Parachute's operations depend on.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Parachute social profiles
Digital presenceParachute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Parachute leadership team
Management profileNumber of profiles
Profiles1 record
Parachute funding detail
Funding detailFunding overview
Funding rounds6 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Parachute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Parachute
What does Parachute do?
Parachute (Join Parachute, LLC) operates a network of plasma donation centers across the United States where individuals can donate plasma for compensation. The company uses plasmapheresis to collect plasma, which is then sold to fractionation facilities for the production of life-saving medicines. Donors are supported through a proprietary mobile application that enables appointment booking, real-time earnings tracking, and same-day compensation.
Is Parachute a public or private company?
Parachute is a private company. It is classified as venture growth investor backed and is currently operating.
When was Parachute founded?
Parachute was founded in 2021. It employs 101 to 250 people.
Where is Parachute based?
Parachute is headquartered in Austin, United States, in the North America region.
How does Parachute make money?
One revenue line is on record: plasma Collection and Sale.
Who are Parachute's main competitors?
Broad incumbents on record are CSL Plasma and Grifols Plasma. Direct peers are BioLife Plasma Services, Octapharma Plasma, Kedrion (U.S. operations), BPL Plasma and Immunotek BioCenters. ADMA BioCenters is listed as an emerging player. Plasma Biological Services / PlasmaSource is listed as a regional player. Haemonetics is listed as an others.
Does Parachute have an API?
No public API is recorded for Parachute.
What industry is Parachute in?
Parachute's product category is Plasma Donation Services. Its primary akta.pro industry code is HLAIAHAH, Plasma Collection & Donor Services (Plasmapheresis Centers).